Literature DB >> 26932412

Letter: new treatments for hepatitis C have implications for quality of life in people who inject drugs.

P Higgs1,2, C Wright3, M Hellard3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26932412     DOI： 10.1111/apt.13538

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  1 in total

1.  Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy.

Authors:  D M Evon; J Amador; P Stewart; B B Reeve; A S Lok; R K Sterling; A M Di Bisceglie; N Reau; M Serper; S Sarkar; J K Lim; C E Golin; M W Fried
Journal:  Aliment Pharmacol Ther       Date:  2018-01-29       Impact factor: 8.171
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.